目的 研究急诊内科老年重症心力衰竭患者的临床治疗方法。方法 抽取本院急诊科2015年接治的120例老年重症心 力衰竭患者为研究对象，回顾分析全部患者的临床资料，并且按照治疗方法进行分组，将接受利经典模式(即尿剂+ 洋地黄)治疗的60例老年重症心力衰竭患者分配至对照组，将接受β阻滞剂联合ARB血管紧张素拮抗剂以及利尿剂治 疗的另外60例老年重症心力衰竭患者分配至观察组，对比两组心衰患者的临床疗效。结果 观察组老年重症心力衰 竭患者的临床疗效要明显优于对照组，并且不良反应情况也要优于对照组，两组老年重症心力衰竭患者之间的疗效 差异以及不良反应差异显著，P<0.05。结论 β阻滞剂联合ARB血管紧张素拮抗剂治疗老年重症心衰的临床效果要优 于经典模式(即尿剂+洋地黄)，并且不良反应少，值得在临床上推广。

Objective To study the emergency medicine in elderly patients with severe heart failure in clinical treatment. Methods Extraction hospital emergency department 120 cases of elderly patients with severe heart failure patients received treatment in 2015 for the study, all patients were retrospectively analyzed and grouped according to the method of treatment will receive profit classic mode (ie diuretics Digitalis + ) treatment of 60 elderly patients with severe heart failure patients assigned to the control group will receive β blocker ARB angiotensin antagonists, and diuretics another 60 elderly patients with severe heart failure patients assigned to the study group, compared two groups of heart clinical efficacy failure patients. Results The clinical efficacy in elderly group of patients with severe heart failure is significantly better than the control group, and adverse reactions should be better than the control group, the difference in efficacy between the two groups of elderly patients with heart failure and severe adverse effects were significantly different, P < 0.05. Conclusion β blocker ARB angiotensin antagonist therapy clinical effect of elderly patients with severe heart failure better than the classic mode (ie diuretics + digitalis), and fewer adverse reactions, should be promoted in clinical practice.